Case File №
#VI-2026-0507
Marvel Peptide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
34 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 8.6 | 8.6 | 8.6 | 25 May 2026 |
| ACE-031 | X N/A | 1 | 4.0 | 0.2 | 0.2 | 28 Mar 2025 |
| Anadrol (Oxymetholone) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| BAC Water | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Feb 2025 |
| Cerebrolysin | X N/A | 1 | 4.0 | 2.1 | 2.1 | 9 Jun 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 28 Mar 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 4.0 | 0.8 | 0.8 | 3 Jul 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 4.0 | 0.7 | 0.7 | 2 Apr 2025 |
| DNP | X N/A | 1 | 4.0 | 0.5 | 0.5 | 6 May 2025 |
| EPO | X N/A | 1 | 4.0 | 1.7 | 1.7 | 16 Mar 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| HMG | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| Humanin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Hyaluronic acid | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Letrozole | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| Lipo-C FAT BLASTER | X N/A | 1 | 4.0 | 2.4 | 2.4 | 28 Mar 2025 |
| Methylamine (base) CAS 74-89-5 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| NA Selank Amidate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 4.0 | 0.3 | 0.3 | 13 Jun 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 | X N/A | 1 | 4.0 | 1.8 | 1.8 | 3 Jul 2025 |
| PMK methyl glycidate CAS 1369021-80-6 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 28 Mar 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| Retatrutide Raw | X N/A | 1 | 4.0 | 2.0 | 2.0 | 27 Feb 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Selank | X N/A | 1 | 4.0 | 0.0 | 0.0 | 8 Jul 2025 |
| SNAP-8 | X N/A | 1 | 4.0 | 1.1 | 1.1 | 16 Mar 2025 |
| Superdrol | X N/A | 1 | 4.0 | 0.1 | 0.1 | 20 Jun 2025 |
| Sustanon 400 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| Test Enanthate | X N/A | 1 | 4.0 | 0.4 | 0.4 | 2 Apr 2025 |
| Turinabol Raw | X N/A | 1 | 4.0 | 0.7 | 0.7 | 6 May 2025 |
| Turinabol | X N/A | 1 | 4.0 | 2.2 | 2.2 | 8 Jul 2025 |
| Vesugen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 20 Jun 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
Exhibit II
Evidence Log
33 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Turinabol Raw | 4.0 C | 5g | 4.6g | -7.6% | 96.55% | mn2mmz | Lab F | Public |
| 23 May 2026 | BAC Water | 4.4 C | 20mg | 18.0mg | -9.9% | 98.30% | htz695 | Lab G | Public |
| 23 May 2026 | DHB (1-Test Cyp) Oral | 4.0 C | 20mg | 17.9mg | -10.5% | 97.33% | l1y3h0 | Lab F | Public |
| 23 May 2026 | Test Enanthate | 4.0 C | 300mg/ml | 320.2mg/ml | +6.7% | 95.48% | didjta | Lab D | Community |
| 23 May 2026 | Vesugen | 4.0 C | 5mg | 4.3mg | -14.2% | 97.53% | takbol | Lab C | Community |
| 21 May 2026 | Letrozole | 4.0 C | 10mg | 9.7mg | -3.0% | 99.68% | 0nankj | Lab E | Community |
| 21 May 2026 | Retatrutide 30mg Pen Kit | 4.8 C | 30mg | 31.0mg | +3.4% | 95.14% | rn3lak | Lab E | Community |
| 21 May 2026 | Selank 10mg + Semax 10mg Blend | 5.9 B | 30mg | 36.9mg | +23.1% | 98.77% | 1v6rvc | Lab F | Public |
| 19 May 2026 | HMG | 4.0 C | 15mg | 18.4mg | +22.6% | 98.74% | h3ryw6 | Lab A | Community |
| 19 May 2026 | PMK methyl glycidate CAS 1369021-80-6 | 4.2 C | 100g | 100.6g | +0.6% | 99.08% | qjs573 | Lab B | Public |
| 17 May 2026 | Anadrol (Oxymetholone) | 4.1 C | 25mg | 22.5mg | -10.0% | 99.06% | j6n2s1 | Lab E | Community |
| 29 Jan 2026 | Turinabol | 4.0 C | 20mg | 19.1mg | -4.3% | 98.15% | zpyr3g | Lab A | Community |
| 26 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.3 C | 2mg | 2.4mg | +17.8% | 98.79% | sdoarn | Lab D | Community |
| 19 Jan 2026 | Retatrutide Raw | 4.0 C | 100g | 91.1g | -8.9% | 95.09% | jsh8aw | Lab A | Public |
| 9 Jan 2026 | Hyaluronic acid | 5.5 B | 15mg | 13.4mg | -10.6% | 99.40% | wy4n3r | Lab F | Public |
| 6 Jan 2026 | Humanin | 4.0 C | 20mg | 18.9mg | -5.3% | 98.87% | 30xv57 | Lab E | Community |
| 6 Jan 2026 | Lipo-C FAT BLASTER | 5.9 B | 250mg/ml | 312.1mg/ml | +24.8% | 98.15% | kesu9k | Lab A | Community |
| 6 Jan 2026 | Superdrol | 4.7 C | 20mg | 17.1mg | -14.3% | 97.42% | 0kf0vf | Lab G | Public |
| 29 Dec 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.0 C | 20mg | 20.8mg | +3.8% | 98.50% | zh1eog | Lab G | Public |
| 29 Dec 2025 | Ostarine (MK-2866) | 4.0 C | 100mg | 110.6mg | +10.6% | 95.77% | 6e6om6 | Lab D | Public |
| 12 Dec 2025 | Methylamine (base) CAS 74-89-5 | 4.9 C | 5g | 6.1g | +22.5% | 95.72% | qwczbd | Lab C | Public |
| 12 Dec 2025 | Selank | 6.7 A | 15mg | 17.5mg | +16.9% | 97.13% | ch0t81 | Lab A | Public |
| 17 Nov 2025 | SNAP-8 | 4.5 C | 15mg | 16.1mg | +7.3% | 95.02% | a4khf3 | Lab A | Community |
| 17 Nov 2025 | Sustanon 400 | 4.0 C | 100mg/ml | 104.7mg/ml | +4.7% | 97.16% | iwx7uv | Lab F | Community |
| 14 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.2 C | 5mg | 4.6mg | -7.8% | 95.41% | pxo9l4 | Lab D | Public |
| 14 Nov 2025 | Vitamin B12 1mg/ml | 4.0 C | 250mg/ml | 251.8mg/ml | +0.7% | 99.02% | vuj3kx | Lab E | Community |
| 5 Nov 2025 | EPO | 5.6 B | 2mg | 1.7mg | -14.6% | 97.69% | f7hbnh | Lab C | Public |
| 17 Oct 2025 | DNP | 4.0 C | 50mg | 43.8mg | -12.4% | 95.23% | zyp9en | Lab A | Public |
| 9 Oct 2025 | ACE-031 | 4.0 C | 2mg | 1.8mg | -9.4% | 97.42% | u266d0 | Lab E | Public |
| 9 Oct 2025 | Cerebrolysin | 4.0 C | 15mg | 16.1mg | +7.0% | 97.17% | fw3ggt | Lab G | Public |
| 9 Oct 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 5.9 B | 10mg | 10.6mg | +6.4% | 98.54% | 5bhogc | Lab C | Community |
| 9 Oct 2025 | NA Selank Amidate | 4.0 C | 15mg | 16.1mg | +7.5% | 98.02% | 8qx75l | Lab G | Public |
| 9 Oct 2025 | Phenethyl bromide (2-bromoethylbenzene) CAS 103-63-9 | 5.3 B | 500g | 523.0g | +4.6% | 95.14% | rbi1be | Lab B | Public |
— END OF EVIDENCE LOG —